These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 292450)

  • 21. Leukaemia-associated antigen (LAA) in proliferative blood disorders.
    Stavem P; Berg K; Noer G
    Scand J Haematol; 1977 Jan; 18(1):13-9. PubMed ID: 265091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization: cell membrane antigens associated with the blast phase of human adult leukemia.
    Hollinshead AC; Herberman RB
    Bibl Haematol; 1975; (40):339-48. PubMed ID: 1057947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells.
    Pegrum GD; Evans CA; Middleton VL; Balfour IC
    Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
    Billing RJ; Foon KA; Linker-Israeli M
    Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction.
    Ashman LK
    Aust J Exp Biol Med Sci; 1983 Aug; 61 (Pt 4)():477-88. PubMed ID: 6228214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen solubilized from human leukemia: lymphocyte stimulation.
    Gutterman JU; Mavligit G; McCredie KB; Bodey GP; Freireich EJ; Hersh EM
    Science; 1972 Sep; 177(4054):1114-5. PubMed ID: 4506296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
    Taylor GM; Harris R; Freeman CB
    Br J Cancer; 1976 Feb; 33(2):137-43. PubMed ID: 1063029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte migration studies in chronic myeloid leukemia (CML). Specificity of reactions.
    Gothoskar BP; D'Silva H; Gharpure H; Advani SH
    Eur J Cancer (1965); 1976 Oct; 12(10):815-21. PubMed ID: 61861
    [No Abstract]   [Full Text] [Related]  

  • 32. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of human leukaemia associated antigens in leukaemic serum and normal embryos.
    Harris R; Viza D; Todd R; Phillips J; Sugar R; Jennison RF; Marriott G; Gleeson MH
    Nature; 1971 Oct; 233(5321):556-7. PubMed ID: 4329823
    [No Abstract]   [Full Text] [Related]  

  • 34. Surface immunoglobulins and protease inhibitors of human acute leukemia blasts.
    Cotropia JP; Gutterman JU; Hersh EM; Mavligit GM
    Int J Cancer; 1977 Oct; 20(4):520-31. PubMed ID: 410736
    [No Abstract]   [Full Text] [Related]  

  • 35. [Differentiation antigens of malignant leukocytes (2)].
    Bernard A; Boumsell L
    Presse Med; 1984 Nov; 13(39):2371-4, 2379-80. PubMed ID: 6239204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
    Zier KS; Huber C; Albert E; Braunsteiner H
    Clin Exp Immunol; 1980 Apr; 40(1):136-46. PubMed ID: 6446429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface antigens on leukaemic myeloid cells. I. Distribution and movement of antigens reacting to antilymphocytic globulins.
    Bacigalupo A; Santini G; Piaggio G; Giordano D; Marmont AM
    Haematologica; 1977 Apr; 62(2):136-43. PubMed ID: 406171
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy versus chemotherapy of acute myeloid leukemia: response to PHA, allogeneic lymphocytes, and leukemic myeloblasts of remission lymphocytes from leukemia patients.
    Reizenstein P; Ogier C; Sjögren AM
    Recent Results Cancer Res; 1980; 75():29-36. PubMed ID: 6940210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions.
    Datta AR; Barrett AJ; Jiang YZ; Guimarães A; Mavroudis DA; van Rhee F; Gordon AA; Madrigal A
    Bone Marrow Transplant; 1994 Oct; 14(4):517-24. PubMed ID: 7858526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cells.
    Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W; Raderecht C; Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):463-74. PubMed ID: 83265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.